<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Vorobjeva NV</submitter><journal>Frontiers in pharmacology</journal><pagination>609508</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7878366</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19.</pubmed_title><pmcid>PMC7878366</pmcid><pubmed_authors>Vorobjeva NV</pubmed_authors><pubmed_authors>Chernyak BV</pubmed_authors><pubmed_authors>Sud'ina GF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-22T16:14:13.937Z</modification><creation>2025-02-19T04:53:15.442Z</creation></dates><accession>S-EPMC7878366</accession><cross_references><pubmed>33584318</pubmed><doi>10.3389/fphar.2021.609508</doi></cross_references></HashMap>